Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 01, 2016
Eagle Pharmaceuticals has announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation to its RYANODEX® (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke (“EHS”), an ...
read more
Monday, February 01, 2016
Gilead Sciences has announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of the company. John F. Milligan, PhD, currently President and Chief Operating Officer, will be ...
read more
Monday, February 01, 2016
WAVE Life Sciences Ltd., a genetic medicine company focused on advancing potential best-in-class stereopure nucleic acid therapies, has announced its plan to deliver six clinical programs by 2018.
read more
Monday, February 01, 2016
Dr. Reddy's Laboratories has announcedthat the U.S. Food and Drug Administration tentative approval for Zenavod™ (doxycycline) Capsules, 40 mg. Zenavod is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and...
read more
Monday, February 01, 2016
Bristol-Myers Squibb Company and Pfizer have announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. to develop and commercialize the investigational agent andexanet alfa in Japan. Andexanet alfa, ...
read more
Monday, February 01, 2016
Vetter, a contract development and manufacturing organization (CDMO) committed to providing customers with the manufacture of high quality drug products, has announced that following approximately two years of construction, its Schuetzenstrasse multi...
read more
Wednesday, January 27, 2016
Eli Lilly and Company has announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
read more
Wednesday, January 27, 2016
MD Biosciences has announced the addition of its suite of in vivo and in vitro cancer models to its family of preclinical contract research services.
read more
Tuesday, January 26, 2016
Medidata a global provider of cloud-based solutions for clinical research in life sciences, announced that ONO Pharmaceutical Co., Ltd. (“ONO”) has expanded its adoption of the Medidata Clinical Cloud® to include all clinical trials testing the use ...
read more
Tuesday, January 26, 2016
ClinTec International has announced the appointment of Dr Robert Reekie as Chief Operating Officer (COO) & Senior Executive Vice President, as it continues to demonstrate strong growth and international expansion.
read more
Tuesday, January 26, 2016
Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by ...
read more
Tuesday, January 26, 2016
Aeterna Zentaris Inc. has filed an international patent application as well as national patent applications in selected countries including the US, China, Taiwan, Japan and India. These applications seek to protect the novel method of manufacturing ...
read more
Piramal Critical Care, an integral business unit of Piramal Enterprises Limited and Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology, have officially launched a co-promotion of ...
read more
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive...
read more
Recipharm has announced the appointment of Anke Mollowitz to the role as Key Account Director. Anke has joined the Business Management team and is responsible for coordinating customer management and commercial aspects, as well as developing ...
read more